Hemiparetic Cerebral Palsy
Conditions
Keywords
Pediatric CI Therapy, ACQUIREc Therapy, Dosage, Occupational Therapy, Physical Therapy, Cerebral Palsy, Hemiparesis
Brief summary
A multisite trial to testing different dosage levels of a systematic form of Pediatric Constraint-Induced (CI) Therapy called ACQUIREc Therapy. The high dosage treatment involved 6 hours of daily therapy services for 21 days. This was compared to a moderate dosage level of 3 hours of daily therapy services for 21 days. It was hypothesized that children receiving the higher therapy dosage would have greater and more clinically significant benefits from ACQUIREc Therapy but that both groups of children would benefit from the therapy services.
Interventions
OTHERTherapy services (ACQUIREc Therapy)
Dosage levels that are associated with the efficacy of intensive therapeutic services provided by OT and PT professionals.
Sponsors
University of Alabama at Birmingham
Study design
Allocation
RANDOMIZED
Intervention model
FACTORIAL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)
Eligibility
Sex/Gender
ALL
Age
3 Years to 8 Years
Healthy volunteers
No
Inclusion criteria
* Children 3-6 years of age * Hemiparetic CP
Exclusion criteria
* No prior CI therapy treatments * No Botox for 6-months
Countries
United States
Outcome results
None listed